https://www.novumpr.nl/2018/12/03/celgene-corporation-and-acceleron-pharma-announce-results-of-the-phase-3-medalist-trial-evaluating-luspatercept-in-patients-with-myelodysplastic-syndromes-at-the-ash-2018-plenary-session/?utm_source=rss&utm_medium=rss&utm_campaign=celgene-corporation-and-acceleron-pharma-announce-results-of-the-phase-3-medalist-trial-evaluating-luspatercept-in-patients-with-myelodysplastic-syndromes-at-the-ash-2018-plenary-session NovumPR press releases Mon, 03 Dec 2018 08:44:07 +0000 hourly 1 https://wordpress.org/?v=6.8.3